| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |